The findings of a Chinese-led international study into regional variations in reference ranges and models of diseases clearly related to dysbiosis in the gut microbiome could have important public health implications for managing disorders including fatty liver and other metabolic diseases.
Australian researchers have identified for the first time in decades a previously unknown immune system microstructure, which they have demonstrated to be responsible for immunological memory. This is a key finding, as it may be used to rapidly mobilize secondary antibody responses and improve vaccine efficacy, the researchers wrote in a study published In the Aug. 22, 2018, edition of Nature Communications.
The findings of a Chinese-led international study into regional variations in reference ranges and models of diseases clearly related to dysbiosis in the gut microbiome could have important public health implications for managing disorders including fatty liver and other metabolic diseases.
Australian researchers have identified for the first time in decades a previously unknown immune system microstructure, which they have demonstrated to be responsible for immunological memory.
A novel means of modeling sporadic amyotrophic lateral sclerosis (SALS) using motor neurons derived from induced pluripotent stem (iPS) cells should provide new insights into the pathology of the disease, researchers reported in the Aug. 20, 2018, edition of Nature Medicine.
A novel means of modeling sporadic amyotrophic lateral sclerosis (SALS) using motor neurons derived from induced pluripotent stem (iPS) cells should provide new insights into the pathology of the disease, researchers reported in the Aug. 20, 2018, edition of Nature Medicine.
An elevated tumor mutational burden (TMB) in the blood has now demonstrated its potential as a reliable clinical biomarker for predicting the clinical efficacy of the checkpoint inhibitor Tecentriq (atezolizumab, Roche Holding AG) in treating patients with advanced non-small-cell lung cancer (NSCLC), a Sino-U.S. study has shown.